Wegovy vs Ozempic in Calgary: Why the Distinction Matters
Both Ozempic and Wegovy contain semaglutide — the same active ingredient. So why are Calgary patients and physicians increasingly specifying Wegovy rather than Ozempic for weight loss? The answer comes down to dosing, Health Canada approval, and clinical outcomes.
Ozempic was approved for Type 2 diabetes at doses up to 1 mg per week in Canada. Wegovy was specifically approved for chronic weight management at doses up to 2.4 mg per week — a dose that produces meaningfully better weight loss results. Wegovy, prescribed on-label for weight management, is the correct tool for the job.
"Wegovy is not just Ozempic rebranded. The higher approved dose for weight management is what unlocks the 15 to 17 percent body weight loss results seen in clinical trials."
The STEP Trial Results: What Calgary Patients Should Know
Novo Nordisk's STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the most comprehensive weight loss drug trial series in history. Key highlights:
- STEP 1: Adults without diabetes lost an average of 14.9 percent of body weight vs 2.4 percent with placebo over 68 weeks
- STEP 5: Weight loss maintained and in some cases continued through 104 weeks (2 years)
- SELECT trial: Wegovy reduced risk of major cardiovascular events by 20 percent in adults with established heart disease
- STEP 8: Head-to-head vs liraglutide (Saxenda) — semaglutide produced 3x greater average weight loss
Wegovy Dose Escalation at Calgary MediSpa
Your physician will guide you through the following titration over 16 to 20 weeks to minimize side effects:
- Weeks 1 to 4: 0.25 mg per week (initiation dose)
- Weeks 5 to 8: 0.5 mg per week
- Weeks 9 to 12: 1.0 mg per week
- Weeks 13 to 16: 1.7 mg per week
- Week 17 onward: 2.4 mg per week (maintenance dose)
Who Is a Candidate for Wegovy in Calgary?
- BMI of 30 or higher, OR
- BMI of 27 or higher with at least one weight-related condition (hypertension, Type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
- Not pregnant or planning pregnancy
- No personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
- No history of pancreatitis
Wegovy Availability and Cost in Calgary in 2026
Supply of Wegovy in Canada improved significantly through late 2025 and into 2026. Most patients can access Wegovy at licensed pharmacies across Calgary without the wait times that characterized the 2023 to 2024 shortage period. Out-of-pocket monthly costs at 2.4 mg/week are typically $300 to $450 per month. Wegovy is not currently covered under the Alberta Drug Benefit (ADB) formulary, though many private extended health plans now cover it with prior authorization.
Frequently Asked Questions
Can my family doctor prescribe Wegovy in Calgary?
Yes — any licensed physician in Alberta can prescribe Wegovy for eligible patients. However, many family doctors have limited time for the ongoing monitoring that optimizes outcomes. A dedicated weight loss clinic like Calgary MediSpa offers physician prescribing plus structured follow-up and program management built in.
What happens when I stop taking Wegovy?
Clinical data shows most patients regain a significant portion of lost weight within 12 months of stopping semaglutide. This reflects obesity as a chronic condition requiring ongoing treatment. Your physician will help you develop a long-term maintenance strategy.
Is Wegovy covered by Alberta Blue Cross?
Coverage varies by plan type and employer benefit package. Some Alberta Blue Cross plans cover Wegovy with prior authorization. We will help you submit a benefits inquiry at your first appointment and can provide supporting physician documentation if required.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before undergoing any medical procedure.